Male Infertility Market Players:
- Andrology Solutions
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck
- Vitrolife Group
- HalotechDNA
- Bayer AG
- SCSA Diagnostics, Inc.
- Examen
- Posterity Health
- ExSeed Health
- Carrot Fertility
- Reproductive Medicine Associates
The male infertility market is competitive with global, regional, and local players vying for market share. Key market players in national and global markets are focusing on acquisitions, research and development, and product launches for early fertility care to increase their market revenue shares.
Some of the key players in the male infertility market are:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of male infertility is estimated at USD 4.8 billion.
The global male infertility market size crossed USD 4.59 billion in 2025 and is likely to expand at a CAGR of more than 5.1%, surpassing USD 7.55 billion revenue by 2035.
North America male infertility market will account for 46.40% share by 2035, driven by increasing awareness and innovations in ART for infertility care.
Key players in the market include Andrology Solutions, Merck, Vitrolife Group, HalotechDNA, Bayer AG, SCSA Diagnostics, Inc., Examen, Carrot Fertility.
